Sabína Oreská

5.3k total citations · 1 hit paper
37 papers, 4.2k citations indexed

About

Sabína Oreská is a scholar working on Pathology and Forensic Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Sabína Oreská has authored 37 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 15 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in Sabína Oreská's work include Systemic Sclerosis and Related Diseases (17 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Muscle Physiology and Disorders (7 papers). Sabína Oreská is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Inflammatory Myopathies and Dermatomyositis (14 papers) and Muscle Physiology and Disorders (7 papers). Sabína Oreská collaborates with scholars based in Czechia, United States and Slovakia. Sabína Oreská's co-authors include Michal Tomčík, Jiří Vencovský, Hana Štorkánová, Maja Špiritović, Barbora Heřmánková, Ladislav Šenolt, Karel Pavelká, Martin Komarc, Radim Bečvář and Kristýna Bubová and has published in prestigious journals such as The Journal of Physiology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sabína Oreská

34 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

2021 4.1k citations Hana Štorkánová, Sabína Oreská et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabína Oreská Czechia	8	803	595	491	420	334	37	4.2k
Hana Štorkánová Czechia	8	803 1.0×	592 1.0×	491 1.0×	420 1.0×	334 1.0×	34	4.2k
Barbora Heřmánková Czechia	8	803 1.0×	587 1.0×	491 1.0×	420 1.0×	334 1.0×	29	4.2k
Maja Špiritović Czechia	10	803 1.0×	605 1.0×	491 1.0×	420 1.0×	334 1.0×	39	4.3k
Kristýna Bubová Czechia	7	802 1.0×	560 0.9×	491 1.0×	420 1.0×	333 1.0×	17	4.2k
Radim Bečvář Czechia	11	807 1.0×	668 1.1×	491 1.0×	420 1.0×	333 1.0×	36	4.4k
Martin Komarc Czechia	22	876 1.1×	732 1.2×	680 1.4×	438 1.0×	334 1.0×	82	5.4k
Michal Tomčík Czechia	27	818 1.0×	1.5k 2.6×	492 1.0×	421 1.0×	334 1.0×	91	6.4k
Nenad Nikolić Austria	2	1.1k 1.3×	1.0k 1.7×	766 1.6×	676 1.6×	358 1.1×	2	6.5k
Johannes Matiasek Austria	10	1.1k 1.3×	1.0k 1.7×	767 1.6×	676 1.6×	358 1.1×	21	6.7k
Aldenor Gomes Santos Brazil	10	1.2k 1.5×	1.3k 2.1×	1.0k 2.1×	859 2.0×	399 1.2×	21	7.3k

Countries citing papers authored by Sabína Oreská

Since Specialization

Citations

This map shows the geographic impact of Sabína Oreská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabína Oreská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabína Oreská more than expected).

Fields of papers citing papers by Sabína Oreská

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabína Oreská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabína Oreská. The network helps show where Sabína Oreská may publish in the future.

Co-authorship network of co-authors of Sabína Oreská

This figure shows the co-authorship network connecting the top 25 collaborators of Sabína Oreská. A scholar is included among the top collaborators of Sabína Oreská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabína Oreská. Sabína Oreská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oreská, Sabína, Hana Štorkánová, Ondřej Kodet, et al.. (2025). Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes. Arthritis Research & Therapy. 27(1). 119–119.

Vokurková, Martina, Maja Špiritović, Sabína Oreská, et al.. (2025). Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis. Arthritis Research & Therapy. 27(1). 48–48. 1 indexed citations

Heřmánková, Barbora, Sabína Oreská, Maja Špiritović, et al.. (2024). Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study. The Aging Male. 27(1). 2336630–2336630.

Oreská, Sabína, Barbora Heřmánková, Hana Štorkánová, et al.. (2024). AB1207 RITUXIMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS NON-RESPONSIVE TO CsDMARDs – PRELIMINARY RESULTS OF A PROSPECTIVE, OBSERVATIONAL, MONOCENTRIC STUDY. Annals of the Rheumatic Diseases. 83. 1941–1941. 1 indexed citations

Heřmánková, Barbora, Maja Špiritović, Sabína Oreská, et al.. (2023). Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study. Rheumatology and Therapy. 10(4). 1089–1105. 1 indexed citations

Oreská, Sabína, Hana Štorkánová, Jaroslav Kudlička, et al.. (2023). Cardiovascular risk in myositis patients compared with the general population. Lara D. Veeken. 63(3). 715–724. 9 indexed citations

Štorkánová, Hana, Thuong Trinh‐Minh, Hana Hulejová, et al.. (2023). S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin. Lara D. Veeken. 63(3). 817–825. 6 indexed citations

Štorkánová, Hana, Maja Špiritović, Sabína Oreská, et al.. (2022). Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects. International Journal of Molecular Sciences. 23(19). 11451–11451. 6 indexed citations

Oreská, Sabína, Hana Štorkánová, Jaroslav Kudlička, et al.. (2022). Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study. Frontiers in Medicine. 9. 861419–861419. 7 indexed citations

10.

Špiritović, Maja, Hana Šmucrová, Barbora Heřmánková, et al.. (2022). The effect of a 24-week physiotherapy and occupational therapy program in systemic sclerosis: a monocentric controlled study with follow-up.. PubMed. 40(10). 1941–1950. 4 indexed citations

11.

Vokurková, Martina, Sabína Oreská, Martin Klein, et al.. (2022). MyomiRs in cultured muscle cells from patients with idiopathic inflammatory myopathy are modulated by disease but not by 6-month exercise training. Clinical and Experimental Rheumatology. 40(2). 346–357. 4 indexed citations

12.

Špiritović, Maja, Barbora Heřmánková, Sabína Oreská, et al.. (2021). The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up. Arthritis Research & Therapy. 23(1). 173–173. 16 indexed citations

13.

Štorkánová, Hana, Sabína Oreská, Maja Špiritović, et al.. (2021). Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study. Scientific Reports. 11(1). 1–1. 4074 indexed citations breakdown →

14.

Štorkánová, Hana, Lucie Andrés Cerezo, Sabína Oreská, et al.. (2021). AB0410 S100A4 PLASMA LEVELS CORRELATE WITH DISEASE ACTIVITY, SKIN FIBROSIS AND INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS PATIENTS. Annals of the Rheumatic Diseases. 80. 1233–1233. 2 indexed citations

15.

Heřmánková, Barbora, Maja Špiritović, Sabína Oreská, et al.. (2021). Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study. Lara D. Veeken. 60(11). 5060–5072. 8 indexed citations

16.

Štorkánová, Hana, Martina Vokurková, Martin Klein, et al.. (2021). Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile. Clinical and Experimental Rheumatology. 39(5). 1021–1032. 11 indexed citations

17.

Heřmánková, Barbora, Maja Špiritović, Hana Šmucrová, et al.. (2020). SAT0324 SEXUAL HEALTH IN WOMEN AND MEN WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL STUDY. Annals of the Rheumatic Diseases. 79. 1107–1108. 1 indexed citations

18.

Oreská, Sabína, Maja Špiritović, Hana Štorkánová, et al.. (2020). THU0358 NEGATIVE CHANGES OF BODY COMPOSITION IN MYOSITIS PATIENTS AND THEIR ASSOCIATION WITH DISEASE SPECIFIC CHARACTERISTICS, PHYSICAL ACTIVITY AND NUTRITIONAL STATUS.. Annals of the Rheumatic Diseases. 79. 410–410. 1 indexed citations

19.

Vokurková, Martina, Martin Klein, Michal Tomčík, et al.. (2019). Alterations in activin A–myostatin–follistatin system associate with disease activity in inflammatory myopathies. Lara D. Veeken. 59(9). 2491–2501. 17 indexed citations

20.

Heřmánková, Barbora, Maja Špiritović, Hana Šmucrová, et al.. (2018). THU0399 Female sexual dysfunction in patients with idiopathic inflammatory myopathies. Annals of the Rheumatic Diseases. 77. 414–415. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact